UNSPSC 51282945: Temafloxacin

This classification denotes a quinolone antibiotic with the molecular formula C21H18F3N3O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1WZ12GTT67, chemically known as 3-quinolinecarboxylic acid, 1,4-dihydro-1-(2,4-difluorophenyl)-6-fluoro-7- (3-methyl-1-piperazinyl)-4-oxo- but generally known as temafloxacin, which bears US NIH Compound Identifier 60021. European Medicines Agency schedules Temafloxacin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10877MIG.

UNSPSC 51282945 Temafloxacin is a Commodity code that in practice captures pharmaceutical procurement by state and local health agencies, though recent activity shows state and local buyers acquiring a broader range of antimicrobial and emergency-response medications through piggyback and cooperative purchasing arrangements rather than temafloxacin specifically. The Illinois Department of Public Health awarded a $2,999,999.11 piggyback contract through the MMCAP Infuse consortium to Chartwell Rx LLC for supply of Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets under a 12-month initial term with two renewal options, while Seminole County, Florida has solicited annual procurement of 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems with quarterly deliveries. State and local procurement under this code flows through health departments and county health agencies pursuing both routine pharmaceutical inventory and emergency-response pharmaceuticals to support community health initiatives.

The most recent activity centers on Florida and Illinois, with the Illinois Department of Public Health managing a three-year pharmaceutical supply contract and Seminole County operating a two-year procurement with one-year renewal option for Naloxone and deactivation systems. The Illinois award (solicitation 26482DPHPREPDB53392, completed August 28, 2026) was made through an Invitation for Bid process, while Seminole County's Naloxone procurement (solicitation IFB60459723LAS, posted June 30, 2026, due July 26, 2023) was solicited as a competitive IFB with quarterly delivery requirements to a specified county health building and potentially FEMA funding. Neither procurement applied domestic product preferences or business enterprise set-asides.